Year: 2025

Company prioritizes its interests in other properties, including Airline and Astro Projects CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) — Global Uranium Corp. (“Global Uranium” or the “Company”) announces that it has terminated its option agreement (the “Option Agreement”) with Forum Energy Metals Corp. (“Forum”) relating to the Northwest Athabasca uranium project (“NWA Project”) in Saskatchewan. As a result, the Company does not hold any interest in the NWA Project. The Company’s decision follows a strategic review of the Company’s portfolio of property interests, and reflects the Company’s decision to focus on deploying capital toward its property interests in Wyoming, where a recently completed radiometric survey identified key uranium anomalies on the Airline #2 property, and its interests in properties in other areas...

LONG BEACH, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced it is expediting a dedicated Electron mission for the Korea Advanced Institute of Science and Technology (KAIST) and is scheduling the launch from Launch Complex 1 in less than 24 hours’ time. The mission, named ‘Bridging The Swarm’, is scheduled to launch no earlier than Thursday, December 11 UTC from Rocket Lab Launch Complex 1 in New Zealand. The mission now precedes the upcoming launch for the Japan Aerospace Exploration Agency (JAXA). This launch rescheduling is a demonstration of Rocket Lab’s operational efficiency, responsiveness, and flexibility to meet the ever-evolving needs of its customers, while continuing to launch more missions...

TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB) (“RWB” or the “Company”) announces that, further to its news release dated December 1, 2025, it has issued 375,000 common shares at a deemed price of $0.035 per share to a former consultant to settle certain outstanding obligations for past services. The securities issued pursuant to the settlement are subject to a statutory hold period of four months and one day in accordance with applicable securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States. The securities referred to herein have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any applicable state securities laws. Accordingly,...

SPRINGFIELD, Mo., Dec. 09, 2025 (GLOBE NEWSWIRE) — Paul Mueller Company (OTC: MUEL) today announced the upcoming retirement of Chief Financial Officer Kenneth E. Jeffries and the appointment of Daniel L. Winters as the company’s next CFO, effective Friday, December 5, 2025. Dan previously served as Chief Financial Officer at Hiland Dairy Foods Company in Springfield, Missouri. He holds a degree in Accounting and Finance from the University of Wisconsin–Green Bay. He brings more than 30 years of experience in the manufacturing sector, including multiple executive finance leadership roles. His background in operational finance, industry knowledge, and long-tenured service as a CFO position him well to support the company’s continued growth. “Ken has been instrumental in the company’s progress over the past eleven years,” said David...

Key Opinion Leader, Dr. Ralph DeFronzo presents the “Future of Menin Inhibitors” and discusses icovamenib and its clinical results shared during WCIRDC 2025 in online interviewSAN CARLOS, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical stage diabetes and obesity company, today announced the release of a KOL interview during the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC 2025) featuring Dr. Ralph DeFronzo, Professor of Medicine and Chief of the Diabetes Division at UT Health San Antonio. The interview highlights the growing body of preclinical and clinical findings supporting the use of icovamenib in patients with diabetes. As part of the astr

Pursuit Minerals acquires the Sascha-Marcelina Projects for a total consideration of ~US$1.5 million Mirasol retains a 1.5% NSR royalty. Following the commencement of commercial production, Pursuit Minerals may buy back the first 0.75% within two years for US$1.5 million, and the remaining 0.75% within three years for an additional US$4 million Repayment of CAD$2M towards outstanding shareholder loanVANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) — Mirasol Resources Ltd. (TSX-V: MRZ) (OTC: MRZLF) (the “Company” or “Mirasol”) is pleased to report it has completed the sale of Mirasol`s 100% owned Sascha Project (“Sascha”) located in Santa Cruz province, Argentina to Andara Mining Pty Ltd (“Andara Mining”), a subsidiary of Pursuit Minerals Ltd. (ASX: PUR) (“Pursuit Minerals”). The Company announced the sale on September...

DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) — Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced that it has entered into a sales agreement pursuant to which Strive may issue and sell shares of its Variable Rate Series A Perpetual Preferred Stock, $0.001 par value per share (the “SATA Stock”), having an aggregate offering price of up to $500,000,000 (the “ATM Program”). Strive intends to use the net proceeds from the ATM Program for general corporate purposes, including, among other things, the acquisition of bitcoin and bitcoin-related products and for working capital, the purchase of income generating assets to grow the Company’s business, other capital expenditures, repurchases of shares of the Company’s Class A common stock, par value $0.001 per share, and/or repayment of debt. Strive may also use such...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 09, 2025 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) announces today that it intends to complete a best efforts non-brokered private placement financing of up to 5,714,285 common shares of the Company (each, a “Flow-Through Share”) issued on a “flow-through basis” for proceeds of up to approximately $2,000,000 (the “Offering”). Closing of the Offering is expected to occur on or about December 19, 2025. All securities issued in connection with the Offering will be subject to a statutory hold period of four months and one day. Completion of the Offering is subject to a number of conditions, including without limitation, receipt of TSX Venture Exchange...

VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) — Fancamp Exploration Ltd. (“Fancamp” or the “Corporation”) (TSX Venture Exchange: FNC) is pleased to announce that its Board of Directors has authorized the Corporation to proceed with a normal course issuer bid (the “NCIB”) to purchase for cancellation, from time to time, as the Corporation considers advisable, up to 12,118,116 common shares of the Corporation (“Common Shares”), representing approximately 5% of the Corporation’s current issued and outstanding Common Shares. The NCIB is subject to approval of the TSX Venture Exchange (the “TSX-V”), and the Corporation has filed with the TSX-V a notice of intention to make the NCIB in this regard. Rajesh Sharma, President and CEO of Fancamp, commented, “The NCIB demonstrates our conviction that the current share price...